Amanote Research
Register
Sign In
Intracranial Hypertension and Nasal Fluticasone Propionate
BMJ
doi 10.1136/bmj.323.7314.694
Full Text
Open PDF
Abstract
Available in
full text
Date
September 22, 2001
Authors
M. Oko
A. Johnston
I. R C Swan
Publisher
BMJ
Related search
Systemic Bioavailability of Fluticasone Propionate Administered as Nasal Drops and Aqueous Nasal Spray Formulations
British Journal of Clinical Pharmacology
Pharmacology
Improvement in Asthma Endpoints When Aiming for Total Control: Salmeterol/Fluticasone Propionate Versus Fluticasone Propionate Alone
Primary Care Respiratory Journal
P111 Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Superior to Fluticasone Propionate Alone in Improving Asthma Control
Thorax
Pulmonary
Respiratory Medicine
Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Fluticasone Propionate/Formoterol for COPD Management: A Randomized Controlled Trial
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Austri, a Large Randomized Study in Adolescents and Adults With Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination With Fluticasone Propionate Compared to Fluticasone Propionate Alone
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Systematic Review of the Dose-Response Relation of Inhaled Fluticasone Propionate
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Intranasal Fluticasone Propionate Delivered by Exhalation Delivery System (FLU-EDS) Versus Flonase® Nasal Spray and Flovent® HFA: A Randomized Comparison of Bioavailability
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Basal Cortisol in Asthmatics on Two Different Doses of Fluticasone Propionate
Jornal de Pediatria
Child Health
Pediatrics
Perinatology
